NMC
PHAS
NEA Management Company’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,643,702
| Closed | -$1.17M | – | 61 |
|
|
2022
Q3 | $1.17M | Hold |
6,643,702
| – | – | 0.06% | 52 |
|
|
2022
Q2 | $3.99M | Hold |
6,643,702
| – | – | 0.2% | 48 |
|
|
2022
Q1 | $8.77M | Sell |
6,643,702
-2
| -0% | -$3 | 0.25% | 44 |
|
|
2021
Q4 | $17.3M | Hold |
6,643,704
| – | – | 0.35% | 35 |
|
|
2021
Q3 | $20.7M | Hold |
6,643,704
| – | – | 0.25% | 36 |
|
|
2021
Q2 | $24.7M | Hold |
6,643,704
| – | – | 0.32% | 37 |
|
|
2021
Q1 | $23M | Hold |
6,643,704
| – | – | 0.52% | 37 |
|
|
2020
Q4 | $22.3M | Hold |
6,643,704
| – | – | 0.59% | 34 |
|
|
2020
Q3 | $23.3M | Hold |
6,643,704
| – | – | 0.99% | 29 |
|
|
2020
Q2 | $30.6M | Hold |
6,643,704
| – | – | 1.23% | 21 |
|
|
2020
Q1 | $22M | Hold |
6,643,704
| – | – | 1.15% | 19 |
|
|
2019
Q4 | $40.6M | Hold |
6,643,704
| – | – | 1.92% | 16 |
|
|
2019
Q3 | $27.7M | Hold |
6,643,704
| – | – | 2.29% | 12 |
|
|
2019
Q2 | $87.2M | Buy |
+6,643,704
| New | +$87.2M | 6.11% | 6 |
|